By proceeding, you agree to our Terms of Use and Privacy Policy.
Owlstone Medical is on a mission is to save 100,000 lives and $1.5bn in healthcare costs. We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease.
29-01 September 2022
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.
Event Ended
USA
Paid
Boston
31-02 February 2023
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.
UK
London
08-09 February 2023
Leveraging next gen technologies beyond conventional biomarker drug discovery! MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an intro
San Diego
MarketsandMarkets is here with a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2023 Confex on the 8th - 9th February 2023 in San Diego-USA to discuss advancements and solutions to th
The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product & drug development various small innovative players are o